166 related articles for article (PubMed ID: 38532310)
1. Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage.
Wei S; Xie Q; Liao G; Chen H; Hu M; Lin X; Li H; Peng J
BMC Gastroenterol; 2024 Mar; 24(1):120. PubMed ID: 38532310
[TBL] [Abstract][Full Text] [Related]
2. [Correlation analysis between ICG-R15 and modified Scheuer score in liver tissues of patients with hepatitis B e antigen-positive/negative chronic hepatitis B].
Zhang MM; Zhang SW; Hu X; Bao FY; Pei ZY; Liu YY; Ma AD; Zhang LY
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):565-570. PubMed ID: 34225432
[No Abstract] [Full Text] [Related]
3. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase.
Gao Y; Wang M; Liu X
Microbiol Spectr; 2024 Apr; 12(4):e0394123. PubMed ID: 38426768
[TBL] [Abstract][Full Text] [Related]
4. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
Jiang C; Liu J; Li R; Chen K; Peng W; Fu L; Peng S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):698-706. PubMed ID: 37539572
[TBL] [Abstract][Full Text] [Related]
6. Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone.
Ren S; Wang W; Lu J; Wang K; Ma L; Zheng Y; Zheng S; Chen X
Front Immunol; 2022; 13():1035923. PubMed ID: 36389814
[TBL] [Abstract][Full Text] [Related]
7. Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels.
Yan JY; Li ZQ; Yu ZJ; Kan QC
J Cell Biochem; 2019 Apr; 120(4):6632-6641. PubMed ID: 30368885
[TBL] [Abstract][Full Text] [Related]
8. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B.
Duan M; Chi X; Xiao H; Liu X; Zhuang H
Hepatol Int; 2021 Apr; 15(2):318-327. PubMed ID: 33638049
[TBL] [Abstract][Full Text] [Related]
9. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study.
Wei S; Hu M; Chen H; Xie Q; Wang P; Li H; Peng J
BMC Gastroenterol; 2022 Aug; 22(1):387. PubMed ID: 35978283
[TBL] [Abstract][Full Text] [Related]
11. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
[TBL] [Abstract][Full Text] [Related]
12. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
Diktas H; Karacaer Z; Özturk II; Cicek H
Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
[TBL] [Abstract][Full Text] [Related]
14. Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients.
Zhao J; Bian D; Liao H; Wang Y; Ren Y; Jiang Y; Liu S; Chen X; Hu Z; Duan Z; Lu F; Zheng S
Front Cell Infect Microbiol; 2023; 13():1083912. PubMed ID: 37065191
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic pathological characteristics and factors influencing alanine transaminase value below twice the upper limit of normal in patients with chronic hepatitis B].
Wang XH; Liu XQ; Cai DC; Hu P; Li H
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):483-488. PubMed ID: 37365024
[No Abstract] [Full Text] [Related]
16. Total serum bile acids predict therapy for HBeAg-negative chronic hepatitis B patients with borderline ALT and high HBV DNA.
Xie R; Li J; Zhang H; Wang LM; Huang CR; Chen LW
J Infect Dev Ctries; 2022 Aug; 16(8):1336-1342. PubMed ID: 36099378
[TBL] [Abstract][Full Text] [Related]
17. Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT.
Wu Z; Ma AL; Xie Q; Zhang XQ; Cheng J; Zhang DZ; Wang GQ; Zhao H
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101463. PubMed ID: 32571749
[TBL] [Abstract][Full Text] [Related]
18. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
Demirören K; Kocamaz H; Doğan Y
Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
[TBL] [Abstract][Full Text] [Related]
20. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone.
Wang J; Yan X; Zhu L; Liu J; Qiu Y; Li Y; Liu Y; Xue R; Zhan J; Jiang S; Geng Y; Wan Y; Li M; Mao M; Gao D; Yin S; Tong X; Xia J; Ding W; Chen Y; Li J; Zhu C; Huang R; Wu C
Aliment Pharmacol Ther; 2023 Mar; 57(5):464-474. PubMed ID: 36324235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
